Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
57.02
+0.73 (1.30%)
At close: Mar 27, 2024, 4:00 PM
56.00
-1.02 (-1.79%)
After-hours: Mar 27, 2024, 7:23 PM EDT

BHVN Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
62.77130.8637.4116.05
Research & Development
373.28437.07181.4998.46
Operating Expenses
436.05567.93218.9114.51
Operating Income
-436.05-567.93-218.9-114.51
Other Expense / Income
-26.51.91-6.474.16
Pretax Income
-409.55-569.84-212.43-118.67
Income Tax
-1.380.441.370
Net Income
-408.17-570.28-213.8-118.67
Shares Outstanding (Basic)
71453939
Shares Outstanding (Diluted)
71453939
Shares Change
59.14%13.63%--
EPS (Basic)
-5.73-12.75-5.43-3.01
EPS (Diluted)
-5.73-12.75-5.43-3.01
Free Cash Flow
-334.77-303.76-146.78-78.65
Free Cash Flow Per Share
-4.70-6.79-3.73-2.00
EBITDA
-402.64-568.46-211.04-118.6
Depreciation & Amortization
6.911.391.390.07
EBIT
-409.55-569.84-212.43-118.67
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).